Want to join the conversation?
$ESRX expects 3Q16 adjusted EPS of $1.72-1.76, which represents a 19-21% YoverY growth, and total adjusted claims of 311-321MM. The company is increasing its expected 2017 retention rate for the 2016 selling season to range of 96-98%, excluding impact of remaining Coventry business rolling off in 2017, representing about 1% of claims.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)